Can a Parkinson's pill rekindle interest in life?
NCT ID NCT05182151
Summary
This study tested whether an existing FDA-approved Parkinson's drug called istradefylline could help improve motivation and reduce apathy in people with Parkinson's disease. Over 12 weeks, researchers measured if patients became more engaged in physical activities and hobbies. The study was small and has been terminated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MUSC Movement Disorders Program
Charleston, South Carolina, 29425, United States
Conditions
Explore the condition pages connected to this study.